Akari Murakami

Toon, 7910295, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Correction: Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Correction: Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Journal: Breast cancer (Tokyo, Japan)
Published: September 06, 2026

Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.

Journal: Breast cancer (Tokyo, Japan)
Published: June 04, 2026

Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10).

Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10).

Journal: BMJ open
Published: May 13, 2026

Semaphorin 3F inhibits breast cancer metastasis by regulating the Akt-mTOR and TGFβ signaling pathways via neuropilin-2.

Semaphorin 3F inhibits breast cancer metastasis by regulating the Akt-mTOR and TGFβ signaling pathways via neuropilin-2.

Journal: Scientific reports
Published: October 16, 2024

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.

Journal: Breast cancer (Tokyo, Japan)
Published: August 10, 2023

Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.

Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.

Journal: Journal of Cancer
Published: June 14, 2023

Computer-Aided Detection of Quantitative Signatures for Breast Fibroepithelial Tumors Using Label-Free Multi-Photon Imaging.

Computer-Aided Detection of Quantitative Signatures for Breast Fibroepithelial Tumors Using Label-Free Multi-Photon Imaging.

Journal: Molecules (Basel, Switzerland)
Published: April 16, 2022

A Case of Breast Cancer during Pregnancy Treated with Neoadjuvant Chemotherapy during Pregnancy

A Case of Breast Cancer during Pregnancy Treated with Neoadjuvant Chemotherapy during Pregnancy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: March 17, 2022

Non-traumatic bilateral rectus sheath hematoma during septic disseminated intravascular coagulation.

Non-traumatic bilateral rectus sheath hematoma during septic disseminated intravascular coagulation.

Journal: Radiology case reports
Published: December 16, 2021

A Case of a Rapidly Growing Granulocyte Colony-Stimulating Factor-Producing Squamous Cell Carcinoma of the Breast.

A Case of a Rapidly Growing Granulocyte Colony-Stimulating Factor-Producing Squamous Cell Carcinoma of the Breast.

Journal: Case reports in oncology
Published: May 10, 2021

CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.

CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.

Journal: Life science alliance
Published: April 15, 2021

Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review.

Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review.

Journal: Hereditary cancer in clinical practice
Published: June 06, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026